Intervention

Atezolizumab 1200 MG in 20 ML Injection

ClinicalTrials.gov intervention label

Clinical trials3

Recruiting0

Common conditions4

Lead sponsors shown3

Clinical trials

3 shown

Study to Compare a Mono Atezolizumab Window Followed by a Atezolizumab - CTX Therapy With Atezolizumab - CTX TherapyNCT04770272 · 2021-03-01

Abemaciclib With or Without Atezolizumab in Metastatic Castration Resistant Prostate CancerNCT04272645 · 2020-10-01

Atezolizumab and Varlilumab in Combination With Radiation Therapy for NSCLCNCT04081688 · 2019-09-11

Common conditions

Prostate Cancer1 Refractory Lung Non-Small Cell Carcinoma1 Stage IV Lung Cancer AJCC v81 Triple-negative Breast Cancer1

Leading sponsors

Palleos Healthcare GmbH1 Rutgers, The State University of New Jersey1 University of Michigan Rogel Cancer Center1

Trial status mix

TERMINATED2

WITHDRAWN1

Phase mix

PHASE22

PHASE11

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.